Fig. 3From: Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II triala Loco-regional progression-free survival of all patients (n = 17). b Loco-regional progression-free survival of all patients treated with concurrent radiochemotherapy (n = 16), stratified by median pretreatment gross tumor volume (≤ 33.2 ml vs > 33.2 ml). c Loco-regional progression-free survival of all patients treated with concurrent radiochemotherapy (n = 16), stratified by median metabolic response to induction chemotherapy (deltaSUV ≤ 0.39 vs deltaSUV > 0.39)Back to article page